Your browser doesn't support javascript.
loading
Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline.
Shivani, Subhashree; Kao, Cheng-Yen; Chattopadhyay, Amrita; Chen, Jenn-Wei; Lai, Liang-Chuan; Lin, Wei-Hung; Lu, Tzu-Pin; Huang, I-Hsiu; Tsai, Mong-Hsun; Teng, Ching-Hao; Wu, Jiunn-Jong; Hsieh, Yi-Hsien; Wang, Ming-Cheng; Chuang, Eric Y.
Afiliación
  • Shivani S; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
  • Kao CY; Institute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Chattopadhyay A; Center for Translational Genomic Research, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
  • Chen JW; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Lai LC; Graduate Institute of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Lin WH; Bioinformatics and Biostatistics Core, Center of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan.
  • Lu TP; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Huang IH; Bioinformatics and Biostatistics Core, Center of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan.
  • Tsai MH; Department of Public Health, Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
  • Teng CH; Department of Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States.
  • Wu JJ; Bioinformatics and Biostatistics Core, Center of Genomic and Precision Medicine, National Taiwan University, Taipei, Taiwan.
  • Hsieh YH; Institute of Biotechnology, National Taiwan University, Taipei, Taiwan.
  • Wang MC; Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Chuang EY; Department of Biotechnology and Laboratory Science in Medicine, School of Biomedical Science and Engineering, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
Front Cell Infect Microbiol ; 12: 726256, 2022.
Article en En | MEDLINE | ID: mdl-35558102
ABSTRACT
Rationale and

Objective:

Gut microbiota have been targeted by alternative therapies for non-communicable diseases. We examined the gut microbiota of a healthy Taiwanese population, identified various bacterial drivers in different demographics, and compared them with dialysis patients to associate kidney disease progression with changes in gut microbiota. Study

Design:

This was a cross-sectional cohort study. Settings and

Participants:

Fecal samples were obtained from 119 healthy Taiwanese volunteers, and 16S rRNA sequencing was done on the V3-V4 regions to identify the bacterial enterotypes. Twenty-six samples from the above cohort were compared with fecal samples from 22 peritoneal dialysis and 16 hemodialysis patients to identify species-level bacterial biomarkers in the dysbiotic gut of chronic kidney disease (CKD) patients.

Results:

Specific bacterial species were identified pertaining to different demographics such as gender, age, BMI, physical activity, and sleeping habits. Dialysis patients had a significant difference in gut microbiome composition compared to healthy controls. The most abundant genus identified in CKD patients was Bacteroides, and at the species level hemodialysis patients showed significant abundance in B. ovatus, B. caccae, B. uniformis, and peritoneal dialysis patients showed higher abundance in Blautia producta (p ≤ 0.05) than the control group. Pathways pertaining to the production of uremic toxins were enriched in CKD patients. The abundance of the bacterial species depended on the type of dialysis treatment.

Conclusion:

This study characterizes the healthy gut microbiome of a Taiwanese population in terms of various demographics. In a case-control examination, the results showed the alteration in gut microbiota in CKD patients corresponding to different dialysis treatments. Also, this study identified the bacterial species abundant in CKD patients and their possible role in complicating the patients' condition.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxinas Biológicas / Insuficiencia Renal Crónica / Microbiota / Microbioma Gastrointestinal Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxinas Biológicas / Insuficiencia Renal Crónica / Microbiota / Microbioma Gastrointestinal Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Taiwán